Correlación entre el antígeno prostático específico (P.S.A.) y los hallazgos del centellograma óseo corporal total (COCT)

Archivos Espanoles de Urologia

Volumn 49, Issue 9, 1996, Pages 953-955

  López, Miguel ^a   Montes De Oca, Luis ^a   Bernardo, Norberto ^a   Scorticati Jr , Carlos ^a   Suárez, Pedro ^a   Bencardino, Federico ^a   De Lasa, Tomás ^a   Sotero Falco, Eduardo ^a   Coimbra, Franz ^a   Scorticati, Carlos ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Adenocarcinoma of prostate; Bone scintiscan; Bony symptoms; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; BONE TUMOR; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; SCINTISCANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0030277339     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CHYBOWSKI, F. M. y cols.: "Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer." J. Urol., 145: 313, 1991.
2. OESTERLING, J. E. y cols.: "The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer." JAMA, 269: 57, 1993.
3. OESTERLING, J. E.: "Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications." Urol. Clin. North Am., 120: 14, 1993.
4. OOMMEN, R. y cols.: "Correlation of serum prostate specific antigen levels and bone scintigraphy." BR. J. Radiol., 67: 469, 1994.
5. SISSONS, G. R. y cols.: "Can serun prostate specific antigen replace bone scintigraphy in the follow up of metastatic prostatic cancer." Br. J. Radiol., 65, 1992.
6. PALMER, E. y cols.: "Pain as an indicator of bone metastasis." Acta Radiol., 29: 445, 1988.
7. ANDRIOLE, G. L. y cols.: "Letter to editor." J. Urol., 147: 474, 1992.
8. MILLER, P. D. y cols.: "Prostate specific antigen and bone scan correlation in carcinoma of the prostate " AUA Meeting: 370A. 1991.
9. MOROTE, J. y cols.: "Utilidad de la gammagrafía ósea versus marcadors tumorales (PSA/PAP) en la monitorización del adenocarcinoma de próstata." Actas Urol. Esp., 14: 268, 1990.
10. PERTUSA PENA, C. y cols.: "Cuándo realizar rastreo óseo en el cáncer de próstata." Actas. Urol. Esp , 18: 387, 1994.